Compounds > 2,3-dinor-thromboxane b2

2,3-dinor-thromboxane b2 and Coronary Thrombosis

2,3-dinor-thromboxane b2 has been researched along with Coronary Thrombosis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fitzgerald, DJ; Murphy, NP; Pratico, D1
Fitzgerald, DJ; FitzGerald, GA; Fragetta, J1

Other Studies

2 other study(ies) available for 2,3-dinor-thromboxane b2 and Coronary Thrombosis

ArticleYear
Functional relevance of the expression of ligand-induced binding sites in the response to platelet GP IIb/IIIa antagonists in vivo.
    The Journal of pharmacology and experimental therapeutics, 1998, Volume: 286, Issue:2

    Topics: Acetates; Animals; Binding Sites; Blood Platelets; Coronary Thrombosis; Dogs; Fibrinolytic Agents; Hemorrhage; Oligopeptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Reperfusion Injury; Thromboxane B2; Tissue Plasminogen Activator; Tyrosine

1998
Prostaglandin endoperoxides modulate the response to thromboxane synthase inhibition during coronary thrombosis.
    The Journal of clinical investigation, 1988, Volume: 82, Issue:5

    Topics: 6-Ketoprostaglandin F1 alpha; Animals; Coronary Disease; Coronary Thrombosis; Dibenzothiepins; Dogs; Male; Platelet Aggregation; Prostaglandin Endoperoxides; Prostaglandin Endoperoxides, Synthetic; Thromboxane B2; Thromboxane-A Synthase

1988